Brief: Vicore Pharma Doses First COVID-19 Patient In ATTRACT Study

Vicore Pharma Holding AB

27/07/2020 07:20

July 27 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * VICORE PHARMA DOSES FIRST COVID-19 PATIENT IN THE ATTRACT
STUDY
IN INDIA
    * PRIMARY OBJECTIVE WITH STUDY IS TO INVESTIGATE EFFICACY OF
VP01
(C21) ON COVID-19 INFECTION NOT REQUIRING MECHANICAL VENTILATION
    * BELIEF IS THAT VP01 COULD BYPASS NEGATIVE EFFECTS OF
VIRUSES
LIKE SARS-COV-2 ON PROTECTIVE RAS FUNCTIONS

Source text for Eikon:  ID:nWkr2rp0B2 
Further company coverage:  VICOR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))